DISPUTE SETTLEMENT
DS:European Union — Countervailing Duties on Imports of Biodiesel from Indonesia
This summary has been prepared by the Secretariat under its own responsibility. The summary is for general information only and is not intended to affect the rights and obligations of Members.
See also:
Current status
back to top
Key facts
back to top
Latest document
back to top
Summary of the dispute to date
The summary below was up-to-date at
Consultations
Complaint by Indonesia
On 11 August 2023, Indonesia requested consultations with the European Union with respect to the definitive countervailing duties on imports of biodiesel from Indonesia, as well as the underlying investigation that led to the imposition of these duties.
Indonesia claimed that the definitive countervailing duties on imports of biodiesel from Indonesia and the investigation leading to their imposition appear to be inconsistent with:
- Articles 1.1(a)(1)(i), 1.1(a)(1)(ii), 1.1(a)(1)(iv), 1.1(a)(2), 1.1(b), 1.2, 2.1, 2.4, 12.1, 12.3, 12.4, 12.4.1, 12.7, 12.11, 14, 14(d), 15.1, 15.2, 15.4, 15.5, 15.7, 15.8, 18.3, 19.1, 19.3, 19.4, 21.1, 22.3, 22.4, 22.5 and 32.1 of the SCM Agreement; and
- Articles I:1, VI, VI:3 and XVI:1 of the GATT 1994.
Panel and Appellate Body proceedings
On 13 October 2023, Indonesia requested the establishment of a panel. At its meeting on 26 October 2023, the DSB deferred the establishment of a panel.
At its meeting on 27 November 2023, the DSB established a panel. Argentina, Australia, Brazil, Canada, China, Japan, Norway, the Russian Federation, Singapore, Thailand, Türkiye, the United Kingdom, and the United States reserved their third-party rights.
Following the agreement of the parties, the panel was composed on 14 March 2024.
On 13 September 2024, the Chair of the panel informed the DSB that the case concerned a large number of complex issues and that, due to constraints pertaining to the availability of members of the panel, the first substantive meeting of the panel had been delayed. The Chair also indicated that the first and the second substantive meetings of the panel had then been scheduled without further delays. As a result, the panel did not expect to issue its final report to the parties before June 2025, at the earliest. The Chair also apprised the DSB that the report would be available to the public once it was circulated to the Members in all three official languages, and that the date of circulation depends on completion of translation.
On 22 August 2025, the panel report was circulated to Members.
This dispute concerns Indonesia's complaint against countervailing duties the European Union has applied since 2019 on imports of biodiesel from Indonesia. Indonesia challenged the European Commission's determination that Indonesia maintains certain subsidy programmes to the benefit of such imports, as well as the Commission's determination that the same subsidized imports threaten the EU biodiesel producers with material injury. In addition, Indonesia challenged various procedural aspects of the Commission's underlying anti-subsidy investigation.
Claims related to alleged subsidization provided to the Indonesian biodiesel industry pursuant to certain subsidy programmes
In relation to the Commission's determination that the GOI provides a countervailable subsidy to biodiesel producers through the Oil Palm Plantation Fund (OPPF), the Panel concluded as follows:
- Indonesia has not established that the Commission acted inconsistently with Article 1.1(a)(1) of the SCM Agreement by determining that disbursements from the OPPF to the biodiesel producers constituted a financial contribution by a government or public body;
- Indonesia has not established that the Commission acted inconsistently with Article 1.1(a)(1) of the SCM Agreement by determining that disbursements from the OPPF to biodiesel producers constituted financial contributions in the form of grants;
- Indonesia has not established that the Commission acted inconsistently with Article 1.1(b) of the SCM Agreement by determining that disbursements by the OPPF to biodiesel producers conferred a benefit to Indonesian biodiesel producers;
- Indonesia has not established that the Commission acted inconsistently with Articles 19.1, 19.4 and 21.1 of the SCM Agreement, or Article VI:3 and Article XVI:1 of the GATT 1994, by failing to properly allocate the alleged subsidy amounts resulting from the OPPF payments, or otherwise failing to accurately determine the per unit subsidy amount or impose countervailing duties at the level not exceeding that amount;
- Indonesia has not established that the Commission acted inconsistently with Articles 1.1(a)(1)(ii), 14, 19.3, 19.4 and 32.1 of the SCM Agreement, and Article VI:3 of the GATT 1994, by failing to adjust the amount of the alleged subsidy "to account for discounts granted as well as export levies, transport and credit costs"; by failing to adequately explain its benefit calculation method or ascertain as accurately as possible the amount of subsidization bestowed on the investigated producer; or by failing to levy countervailing duties in the appropriate amounts; and
- Indonesia has not established that the Commission acted inconsistently with Articles 1.2, 2.1 and 2.4 of the SCM Agreement by determining that disbursements from the OPPF, confer a benefit to the recipients which is de jure specific. In light of this finding, the Panel refrained from ruling on Indonesia's additional claims that the Commission acted inconsistently with Articles 1.2, 2.1 and 2.4 of the SCM Agreement by determining that disbursements from the OPPF are de facto specific
In relation to the Commission's determination that the GOI provides a countervailable subsidy to biodiesel producers through the provision of crude palm oil (CPO), the Panel concluded as follows:
- the Commission acted inconsistently with Article 1.1(a)(1)(iv) of the SCM Agreement by determining that, through a set of measures, including an export tax and export levy, and by de facto acting as a price setter in the domestic CPO market, the GOI induced the domestic CPO producers to sell CPO locally and thereby entrusted or directed private CPO suppliers to provide CPO to biodiesel producers in Indonesia for less than adequate remuneration. In light of this finding, the Panel refrained from ruling on Indonesia's additional claim that the Commission acted inconsistently with Article 1.1(a)(1)(iv) of the SCM Agreement by determining that the provision of CPO to biodiesel producers in Indonesia is a type of function which "would normally be vested in the government and the practice, in no real sense, differs from practices normally followed by governments", as specified in Article 1.1(a)(1)(iv);
- the Commission acted inconsistently with Articles 1.1(a)(2) and 32.1 of the SCM Agreement by determining that, through a set of measures, including an export tax and export levy, and by de facto acting as a price setter in the domestic CPO market, the GOI provides income or price support to the biodiesel industry;
- in light of its findings that the Commission acted inconsistently with Article 1.1(a)(1)(iv) and Article 1.1(a)(2) of the SCM Agreement, the Panel refrained from ruling on Indonesia's additional claims that the Commission acted inconsistently with Articles 1.1(b) and 14(d) of the SCM Agreement by determining that CPO suppliers provide CPO to biodiesel producers in Indonesia for less than adequate remuneration, thereby conferring a benefit upon Indonesian biodiesel producers;
- in light of its findings that the Commission acted inconsistently with Article 1.1(a)(1)(iv) and Article 1.1(a)(2) of the SCM Agreement, the Panel also refrained from ruling on Indonesia's additional claims that the Commission acted inconsistently with Articles 1.2, 2.1 and 2.4 of the SCM Agreement by determining that the provision of CPO and provision of income or price support to the biodiesel industry are specific;
- Indonesia has not established that the Commission acted inconsistently with Article 12.7 of the SCM Agreement by resorting to facts available in respect of information concerning Indonesian state-owned enterprise, PT Perkebunan Nusantara (PTPN);
- Indonesia has not established that the Commission acted inconsistently with Article 12.7 of the SCM Agreement by disregarding any information submitted by independent CPO suppliers when making findings concerning whether PTPN depreciated CPO prices in Indonesia; and
- the Commission acted inconsistently with Article 12.7 of the SCM Agreement by resorting to facts available in respect of independent CPO suppliers on the ground that the GOI purportedly failed to ensure submission of independent CPO suppliers' Appendix B responses.
Claims related to the European Commission's determination that imports of biodiesel from Indonesia cause a threat of material injury to EU biodiesel producers
The Panel concluded as follows:
- Indonesia has not established that the Commission acted inconsistently with Articles 15.1 and 15.2 of the SCM Agreement by failing to ensure price comparability, when examining the effect of Indonesian imports on the prices of domestic like products, and by failing to consider the existence of significant price undercutting for the product as a whole;
- the Commission acted inconsistently with Articles 15.1 and 15.2 of the SCM Agreement by failing to make an objective examination, on the basis of positive evidence, of the effect of Indonesian imports on the prices of domestic like products and improperly found significant price depression, in breach of Articles 15.1 and 15.2 of the SCM Agreement;
- the Commission acted inconsistently with Articles 15.1 and 15.4 of the SCM Agreement by failing to make an objective examination, on the basis of positive evidence, of the factors having a bearing on the state of the domestic industry;
- the Commission acted inconsistently with Articles 15.1 and 15.7 of the SCM Agreement by concluding that the totality of threat factors that the Commission examined indicated that "the fragile economic condition of the Union industry is likely to be aggravated by the imminent and continuing subsidised imports of biodiesel from Indonesia";
- the Commission acted inconsistently with Article 15.7 of the SCM Agreement by failing to properly consider the existence of a change in circumstances in its threat of injury determination;
- Indonesia has not established that the Commission acted inconsistently with Article 15.2 of the SCM Agreement in considering that there had been a significant increase in the volume of Indonesian imports;
- in light of inconsistencies in the preceding steps of inquiry into the existence of a threat of material injury and in the absence of a valid finding of material injury or threat thereof, the Panel refrained from ruling on Indonesia's additional claims that the Commission acted inconsistently with Articles 15.5 and 15.7 of the SCM Agreement in assessing whether the subject imports or other known factors were the cause of a threat of material injury to EU biodiesel producers; and
- in light of inconsistencies in the preceding steps of inquiry into the existence of a threat of material injury and in the absence of a valid finding of material injury or threat thereof, the Panel refrained from ruling on Indonesia's claim that the Commission acted inconsistently with Article 15.8 of the SCM by failing to exercise "special care" in the application of countervailing measures.
Claims related to the European Commission's rejection of a price undertaking offer in the investigation:
The panel concluded that Indonesia has not established that the Commission acted inconsistently with Article I:1 of the GATT 1994 and Articles 15.8 and 18.3 of the SCM Agreement by declining a price undertaking offer by Indonesian biodiesel producer, Wilmar, after it had accepted a price undertaking in respect of Argentine exporters.
Claims related to the European Commission's non‑disclosure of certain information:
The Panel concluded as follows:
- Indonesia has not established that the Commission acted inconsistently with Articles 12.1, 12.3, 12.4, and 12.4.1 of the SCM Agreement by failing to require the relevant EU producers to provide a non‑confidential summary of submitted information; and
- Indonesia has not established that the Commission acted inconsistently with Articles 12.1, 12.3, and 15.1 of the SCM Agreement by failing to provide necessary information to interested parties, including necessary information to propose alternative methodologies to determine the existence of price undercutting; or by providing a late disclosure of essential information concerning, among others, price elasticity and changes in the EU market.
Pursuant to Article 19.1 of the DSU, the Panel recommended that the European Union bring its measures into conformity with its obligations under the SCM Agreement.
Panel and Appellate Body proceedings
On 26 September 2025, the European Union notified the DSB of its decision to appeal certain issues of law and legal interpretations in the panel report. The European Union stated its awareness that the Appellate Body was unable to hear the appeal due to an insufficient number of its members. The European Union indicated that it would await further instructions from the division, once composed, or the Appellate Body, on any further steps to be taken by the European Union in this appeal.
Share
Follow this dispute
Problems viewing this page? If so, please contact [email protected] giving details of the operating system and web browser you are using.